{"nct_id":"NCT06132958","title":"Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2023-12-06","start_date_type":"ACTUAL","primary_completion_date":"2028-01-10","primary_completion_date_type":"ESTIMATED","completion_date":"2028-01-10","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}